Skip to main content
. 2023 Sep-Oct;39(5):1422–1428. doi: 10.12669/pjms.39.5.7500

Table-IV.

Regression analysis of variables associated with pain in mammography.

OR (95% CI) p-value aOR (95% CI) p-value
Group
Placebo 3.09 (2.05-4.69) <0.001 3.64 (2.31-5.74) <0.001
Paracetamol Ref Ref
BMI, kg/m2
>25 3.07 (1.68-5.62) <0.001 2.84 (1.43-5.62) 0.003
22.6-25 3.09 (1.57-6.12) 0.001 2.29 (1.07-4.91) 0.032
18.5-22.5 1.12 (0.63-1.98) 0.697 1.18 (0.61-2.27) 0.621
<18.5 Ref Ref
Age at time of marriage, years (n=621)
≤25 1.79 (1.02-3.16) 0.043 2.20 (1.14-4.26) 0.019
>25 Ref Ref
Gravida
Nulligravida 2.73 (1.19-6.27) 0.018 3.56 (1.39-9.09) 0.008
Primigravida 4.43 (0.97-20.17) 0.054 3.81 (0.73-19.59) 0.113
Multigravida 1.48 (0.89-2.45) 0.123 1.50 (0.84-2.68) 0.167
Grand Multigravida Ref Ref
Residence
Rural 0.62 (0.42-0.93) 0.022 0.74 (0.47-1.19) 0.224
Urban Ref Ref
Menstrual status
Menopause 2.74 (1.75-15.16) <0.001 2.23 (1.35-3.68) 0.002
Peri-menopausal 5.94 (2.33-15.16) <0.001 4.51 (1.67-12.18) 0.003
Normal Ref Ref
Family History of Breast Cancer
Yes 2.30 (1.25-4.25) 0.008 2.33 (1.19-4.57) 0.014
No Ref Ref
Reason of test
Screening 0.37 (0.24-0.56) <0.001 1.43 (0.89-2.31) 0.135
Diagnostic 0.24 (0.14-0.42) <0.001 Ref

OR: Odds Ratio, AOR: Adjusted Odds Ratio, CI: Confidence Interval.